Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |